![Can we improve the delivery of eribulin by linking it to a HER2 mAb?](https://oncodaily.com/pub/uploads/2023/06/Paolo-Tarantino-1-1280x1280.jpeg)
Photo from Paolo Tarantino/Twitter
Jun 14, 2023, 18:35
Can we improve the delivery of eribulin by linking it to a HER2 mAb?
In a post by Paolo Tarantino on Twitter, it says, “Can we improve the delivery of eribulin by linking it to a HER2 mAb? In a cohort of 29 patients with HER2-expressing tumors (65% breast), BB-1701 achieved an ORR of 50% (70% for breast), with durable responses. High rates of peripheral neuropathy (69%).”
Source: Paolo Tarantino/Twitter
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2024, 10:15